These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28817980)

  • 1. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
    Shilo NR; Morris CR
    Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
    Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
    JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma management: reinventing the wheel in sickle cell disease.
    Morris CR
    Am J Hematol; 2009 Apr; 84(4):234-41. PubMed ID: 19229984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
    Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
    Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
    Morris CR
    Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell anemia-associated pulmonary arterial hypertension.
    Machado RF
    J Bras Pneumol; 2007; 33(5):583-91. PubMed ID: 18026658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell disease, vasculopathy, and therapeutics.
    Kassim AA; DeBaun MR
    Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on arginine in sickle cell disease.
    Benites BD; Olalla-Saad ST
    Expert Rev Hematol; 2019 Apr; 12(4):235-244. PubMed ID: 30855194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment.
    Pavan AR; Terroni B; Dos Santos JL
    Nitric Oxide; 2024 Aug; 149():7-17. PubMed ID: 38806107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy.
    Morris CR
    Treat Respir Med; 2006; 5(1):31-45. PubMed ID: 16409014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.
    Villagra J; Shiva S; Hunter LA; Machado RF; Gladwin MT; Kato GJ
    Blood; 2007 Sep; 110(6):2166-72. PubMed ID: 17536019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in sickle cell disease.
    Al Kahf S; Roche A; Baron A; Chantalat-Auger C; Savale L
    Presse Med; 2023 Dec; 52(4):104209. PubMed ID: 37967611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary complications of sickle cell disease in children].
    Pincez T; Calamy L; Germont Z; Lemoine A; Lopes AA; Massiot A; Tencer J; Thivent C; Hadchouel A
    Arch Pediatr; 2016 Oct; 23(10):1094-1106. PubMed ID: 27642150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease at the dawn of the molecular era.
    Abboud MR; Musallam KM
    Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
    Kato GJ; Gladwin MT
    JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.